Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Niger. Postgrad. Med. J. ; 29(3): 206-213, 2022. figures, tables
Artículo en Inglés | AIM | ID: biblio-1381142

RESUMEN

Background: Hypertension is the largest contributor to the global burden of disease. Emerging risk factors for cardiovascular disease include blood pressure variability (BPV), but evidence on BPV is lacking among older Nigerians. We reported BPV in a cohort of older persons at the University College Hospital (UCH), Ibadan. Methods: We conducted a retrospective cohort study of respondents aged >50 years within the Ibadan Ambulatory Blood Pressure Registry at the UCH, Ibadan, Nigeria. Socio-demographic characteristics, lifestyle habits and anthropometric measurements were obtained. Results: Among 639 respondents, 332 (52.0%) were female. The blood pressure (BP) variables were strongly associated with age. Compared with younger age groups, mean diastolic BP (DBP) was less at an older age, whereas mean pulse pressure was greater. During the wake-up and sleep periods, mean DBP and mean arterial BP were less with each increasing age category, whereas mean pulse pressure was larger with each increasing age category. BP dipping, systolic, diastolic and mean arterial BP decreased with age. Overall, timed BPV increased significantly with increasing age. The prevalence of white­coat hypertension was greater among older participants than younger participants. Most respondents in the 50­59 years' age group were non-dippers (55.8%), whereas 33.7% of older respondents were reverse-dippers. Conclusion: Older persons experienced a greater abnormal circadian blood variation and greater BPV than younger people. In Nigeria, follow­up data are needed to determine the prognostic significance of these data in this population


Asunto(s)
Humanos , Masculino , Femenino , Anciano de 80 o más Años , Presión Sanguínea , Anciano de 80 o más Años , Monitoreo Ambulatorio de la Presión Arterial , Hipertensión
2.
Niger. j. med. (Online) ; 30(4): 356-361, 2021.
Artículo en Inglés | AIM | ID: biblio-1290631

RESUMEN

Coronavirus disease 2019 (COVID­19) accounts for over 92 million confirmed cases worldwide, with over 2.06 million deaths. In the past year, more than 290 candidate vaccines have been tested; COVID-19 vaccine development was sped up, with shortened timeline, due to the urgent global need in the face of the pandemic. In addition, people with the highest risk of contracting the disease, such as health workers with a high risk of exposure, elderlies, and people with underlying comorbidities, were prioritized with vaccination rollout. The article narratively reviewed original and review articles available on PubMed and Google Scholar related to the theme to provide up­to­date information. The different templates developed and studied for COVID-19 vaccines include the whole-virus vaccine, viral vector vaccine, nucleic acid (deoxyribonucleic acid and ribonucleic acid), and protein subunit vaccine. Myths impede vaccine uptake in this part of the globe. Adopting these myths leads to sharing and spreading, which negatively impacts the prevention of COVID-19 and vaccine uptake. Adverse event following immunizations (AEFIs) is classified based on severity, from minor to severe. The minor ones are common events that pose no potential health risks to the receiver of the vaccine. The type determines the safety profile, severity, and frequency of AEFIs observed with the vaccine administration. Overall, this pandemic has heightened the global level of threat awareness; it has also provided motivation to prepare for future pandemics by developing new vaccines.


Asunto(s)
Humanos , Vacunas contra la COVID-19 , COVID-19 , Vacunas de ADN , Subunidades de Proteína , Nigeria
3.
Ibom Medical Journal ; 13(3): 149-155, 2020.
Artículo en Inglés | AIM | ID: biblio-1262927

RESUMEN

Coronavirus disease (COVID-19) is a respiratory illness currently ravaging the world in pandemic proportions. Its route of spread and a high degree of infectivity make it easily transmissible within health care settings. Health workers, who are at particular risk of workplace-related infection, should be familiar with and abide by international best practices for infection prevention and control at work to protect themselves and their patients. This is particularly important so that they can continue to provide muchneeded care. We present a review of international best practices and guidelines to prevent COVID-19 infection in the clinical space in the Nigerian context. Our focus is on strategies for administrative control, patient management, and environmental cleaning and waste management


Asunto(s)
COVID-19 , Transmisión de Enfermedad Infecciosa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA